Antibody-based inhibition of ADAM10 as cancer immunotherapy

  • Janes, Peter (Primary Chief Investigator (PCI))
  • Moritz, Robert (Chief Investigator (CI))
  • Nikolov, Dimitar (Chief Investigator (CI))
  • Vail, Mary (Chief Investigator (CI))
  • Scott, Andrew (Associate Investigator (AI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1431/12/17

Funding

  • National Health & Medical Research Council (NHMRC): AUD631,226.00